“SYSTEMATIC REVIEW OF THE COST-EFFECTIVENESS OF ABEMACICLIB IN THE TREATMENT OF HR+/HER2− ADVANCED OR METASTATIC BREAST CANCER ” (2026) Vietnam Journal of Community Medicine, 67(10). doi:10.52163/yhc.v67i10.6967.